Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials

被引:15
|
作者
Melzer, Georg [1 ]
Maiwald, Tim [2 ]
Prokosch, Hans-Ulrich [1 ]
Ganslandt, Thomas [1 ,3 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Chair Med Informat, Wetterkreuz 15, D-91058 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Dept Elect Engn, Inst Elect Engn, Erlangen, Germany
[3] Heidelberg Univ, Mannheim Univ Med, Dept Biomed Informat, Heinrich Lanz Ctr Digital Hlth, Mannheim, Germany
来源
APPLIED CLINICAL INFORMATICS | 2021年 / 12卷 / 01期
关键词
electronic health records and systems; data warehousing and data marts; secondary use; clinical trial; recruitment; PATIENT RECRUITMENT; MEDICAL INFORMATICS; SYSTEMS; ROUTINE; IMPACT; REPRESENTATION; QUALITY; CARE;
D O I
10.1055/s-0040-1721010
中图分类号
R-058 [];
学科分类号
摘要
Background Even though clinical trials are indispensable for medical research, they are frequently impaired by delayed or incomplete patient recruitment, resulting in cost overruns or aborted studies. Study protocols based on real-world data with precisely expressed eligibility criteria and realistic cohort estimations are crucial for successful study execution. The increasing availability of routine clinical data in electronic health records (EHRs) provides the opportunity to also support patient recruitment during the prescreening phase. While solutions for electronic recruitment support have been published, to our knowledge, no method for the prioritization of eligibility criteria in this context has been explored. Methods In the context of the Electronic Health Records for Clinical Research (EHR4CR) project, we examined the eligibility criteria of the KATHERINE trial. Criteria were extracted from the study protocol, deduplicated, and decomposed. A paper chart review and data warehouse query were executed to retrieve clinical data for the resulting set of simplified criteria separately from both sources. Criteria were scored according to disease specificity, data availability, and discriminatory power based on their content and the clinical dataset. Results The study protocol contained 35 eligibility criteria, which after simplification yielded 70 atomic criteria. For a cohort of 106 patients with breast cancer and neoadjuvant treatment, 47.9% of data elements were captured through paper chart review, with the data warehouse query yielding 26.9% of data elements. Score application resulted in a prioritized subset of 17 criteria, which yielded a sensitivity of 1.00 and specificity 0.57 on EHR data (paper charts, 1.00 and 0.80) compared with actual recruitment in the trial. Conclusion It is possible to prioritize clinical trial eligibility criteria based on real-world data to optimize prescreening of patients on a selected subset of relevant and available criteria and reduce implementation efforts for recruitment support. The performance could be further improved by increasing EHR data coverage.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 20 条
  • [1] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Scott R. Evans
    Dianne Paraoan
    Jane Perlmutter
    Sudha R. Raman
    John J. Sheehan
    Zachary P. Hallinan
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 545 - 552
  • [2] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Evans, Scott R.
    Paraoan, Dianne
    Perlmutter, Jane
    Raman, Sudha R.
    Sheehan, John J.
    Hallinan, Zachary P.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (03) : 545 - 552
  • [3] Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design
    Xu, Jie
    Zhang, Hao
    Zhang, Hansi
    Bian, Jiang
    Wang, Fei
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [4] Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data
    Johnson, Lorraine
    Shapiro, Mira
    Needell, Deanna
    Stricker, Raphael B.
    HEALTHCARE, 2025, 13 (01)
  • [5] Real-World Eligibility for Clinical Trials in Extensive Stage Small Cell Lung Cancer Patients
    Dehar, N.
    Meem, M.
    Aggarwal, I.
    Hopman, W.
    Gaudreau, P. -O.
    Robinson, A.
    Fung, A. S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S547 - S547
  • [6] Leveraging electronic health record data for clinical trial planning by assessing eligibility criteria's impact on patient count and safety
    Rogers, James R.
    Pavisic, Jovana
    Ta, Casey N.
    Liu, Cong
    Soroush, Ali
    Cheung, Ying Kuen
    Hripcsak, George
    Weng, Chunhua
    JOURNAL OF BIOMEDICAL INFORMATICS, 2022, 127
  • [7] Revolutionizing Medicine: Unleashing the Power of Real-World Data and AI in Advancing Clinical Trials
    Kalidindi, Venkateswara Raju
    Rehana, Sheik
    Seethamraju, Sarvan Manikiran
    Nori, Lakshmi Prasanthi
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 60
  • [8] Toxicities Associated with Sacituzumab Govitecan: Data from Clinical Trials and a Real-World Pharmacovigilance Database
    Tan, Qiao-yun
    Mei, Xiang-ping
    Hu, Yue
    Wu, Hong-ge
    Xie, Lin-ka
    Xiong, Jie
    Yao, Jing
    CURRENT MEDICAL SCIENCE, 2025, : 301 - 313
  • [9] Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation
    Lee, Kyeryoung
    Liu, Zongzhi
    Mai, Yun
    Jun, Tomi
    Ma, Meng
    Wang, Tongyu
    Ai, Lei
    Calay, Ediz
    Oh, William
    Stolovitzky, Gustavo
    Schadt, Eric
    Wang, Xiaoyan
    JMIR AI, 2024, 3
  • [10] Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system
    Ilagan-Ying, Ysabel C.
    Xu, Jin
    Lim, Joseph K.
    Do, Albert
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (03) : 424 - 429